Whilst we are interested in developing TNFα-CSG as an anti-cancer therapeutic, as an imaging agent, CSG-IO-NP may be used for diagnostic screening to identify patients who may benefit from TNFα-CSG therapy. The gene discussed is TNF; the disease is cancer.